Research and Development | RaQualia Pharma Inc.

: At RaQualia Pharma, all of our researchers are focused on the needs of patients waiting for new medicines as we conduct research from the earliest part of the discovery process. Our primary emphasis is on Pain and Gastrointestinal Disease (GI) in the discovery research and early clinical development stages .
: RaQualia Pharma's approach to discovery and research is centered on closely tracking the changing priorities of our customers and consistently producing new development compounds that meet those medical needs. In addition to Pain and GI disease, our strategy is to look for potential in medical fields such as Alzheimer's Disease and Cancer. In doing so we fully utilize a wealth of drug discovery and research experiences gained by our team of experts while working in pharmaceutical companies around the world.
: We believe that our approach to research and development, rooted in our business model of open collaboration with universities, public research institutions, pharmaceutical companies and venture businesses (see the Business Model page for details), drives the discovery and development of innovative new medicines. By pooling these scientists' and researchers' knowledge and technology we can create high value-added development candidates.